These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24127871)

  • 61. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice.
    Nicolas JF; Guy B
    Expert Rev Vaccines; 2008 Oct; 7(8):1201-14. PubMed ID: 18844594
    [TBL] [Abstract][Full Text] [Related]  

  • 62. "IDEAL" vaccines for resource poor settings.
    Levine MM
    Vaccine; 2011 Dec; 29 Suppl 4():D116-25. PubMed ID: 22486974
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recent insights into cutaneous immunization: How to vaccinate via the skin.
    Engelke L; Winter G; Hook S; Engert J
    Vaccine; 2015 Sep; 33(37):4663-74. PubMed ID: 26006087
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination.
    Balmert SC; Carey CD; Falo GD; Sethi SK; Erdos G; Korkmaz E; Falo LD
    J Control Release; 2020 Jan; 317():336-346. PubMed ID: 31756393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
    Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Understanding the basis of transcutaneous vaccine delivery.
    Gamazo C; Pastor Y; Larrañeta E; Berzosa M; Irache JM; Donnelly RF
    Ther Deliv; 2019 Jan; 10(1):63-80. PubMed ID: 30730825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A micro-sterile inflammation array as an adjuvant for influenza vaccines.
    Wang J; Shah D; Chen X; Anderson RR; Wu MX
    Nat Commun; 2014 Jul; 5():4447. PubMed ID: 25033973
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
    Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
    Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Colloidal carrier systems for transcutaneous immunization.
    Gupta PN; Vyas SP
    Curr Drug Targets; 2011 Apr; 12(4):579-97. PubMed ID: 21226670
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transdermal delivery of vaccines - Recent progress and critical issues.
    Ita K
    Biomed Pharmacother; 2016 Oct; 83():1080-1088. PubMed ID: 27544552
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Solid-in-oil nanodispersions for transdermal drug delivery systems.
    Kitaoka M; Wakabayashi R; Kamiya N; Goto M
    Biotechnol J; 2016 Nov; 11(11):1375-1385. PubMed ID: 27529824
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Needle-free vaccine delivery.
    Giudice EL; Campbell JD
    Adv Drug Deliv Rev; 2006 Apr; 58(1):68-89. PubMed ID: 16564111
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel Biomimetic Reconstituted Built-in Adjuvanted Hepatitis B Vaccine for Transcutaneous Immunization.
    Kaurav M; Kumar R; Jain A; Pandey RS
    J Pharm Sci; 2019 Nov; 108(11):3550-3559. PubMed ID: 31348940
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Are there differences in immune responses following delivery of vaccines through acutely or chronically sun-exposed compared with sun-unexposed skin?
    Hart PH; Norval M
    Immunology; 2020 Feb; 159(2):133-141. PubMed ID: 31593303
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cutaneous immunization: an evolving paradigm in influenza vaccines.
    Gill HS; Kang SM; Quan FS; Compans RW
    Expert Opin Drug Deliv; 2014 Apr; 11(4):615-27. PubMed ID: 24521050
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Local and systemic effects of low-level light therapy with light-emitting diodes to improve erythema after fractional ablative skin resurfacing: a controlled study.
    Wanitphakdeedecha R; Iamphonrat T; Phothong W; Eimpunth S; Manuskiatti W
    Lasers Med Sci; 2019 Mar; 34(2):343-351. PubMed ID: 30074109
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Microneedle-Mediated Transcutaneous Immunization: Potential in Nucleic Acid Vaccination.
    Wang H; Xu J; Xiang L
    Adv Healthc Mater; 2023 Sep; 12(23):e2300339. PubMed ID: 37115817
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nanoparticles for transcutaneous vaccination.
    Hansen S; Lehr CM
    Microb Biotechnol; 2012 Mar; 5(2):156-67. PubMed ID: 21854553
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Routing dependent immune responses after experimental R848-adjuvated vaccination.
    van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F
    Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel ablative laser mediated transdermal immunization for microparticulate measles vaccine.
    Joshi D; Gala RP; Uddin MN; D'Souza MJ
    Int J Pharm; 2021 Sep; 606():120882. PubMed ID: 34298102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.